CTI BioPharma Corp.

NASDAQ: CTIC · Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Revenue

CTI BioPharma reported an annual revenue of $53.95M, reflecting a 0% growth. For the quarter ending March 31, 2023, CTI BioPharma generated $24.12M in revenue.
Revenue (ttm)
53.95M
Revenue Growth
n/a
Price / Sales Ratio
12.78
Revenue / Employee
424.79K
Employees
127
Market Cap
1.2B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2022 53.95M +Infinity%
Dec 31, 2021 0 n/a
Dec 31, 2020 0 -100.00%
Dec 31, 2019 3.35M -87.28%
Dec 31, 2018 26.29M +4.55%
Dec 31, 2017 25.15M -56.20%
Dec 31, 2016 57.41M +256.20%
Dec 31, 2015 16.12M -73.17%
Dec 31, 2014 60.08M +73.24%
Dec 31, 2013 34.68M +Infinity%
Dec 31, 2012 0 n/a
Dec 31, 2011 0 -100.00%
Dec 31, 2010 319K +298.75%
Dec 31, 2009 80K -99.30%
Dec 31, 2008 11.43M +8901.57%
Dec 31, 2007 127K +58.75%
Dec 31, 2006 80K -99.50%
Dec 31, 2005 16.09M -45.62%
Dec 31, 2004 29.59M +19.50%
Dec 31, 2003 24.77M +46.57%
Dec 31, 2002 16.9M +170.94%
Dec 31, 2001 6.24M +1142.13%
Dec 31, 2000 502.04K +402.04%
Dec 31, 1999 100K -99.24%
Dec 31, 1998 13.2M +11.86%
Dec 31, 1997 11.8M +29.67%
Dec 31, 1996 9.1M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.